InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Lowdell Mark William, Directeur Scientifique. Director active across 1 company, notably Inmune Bio, Inc.. Cumulatively, 8 reports have been recorded. Breakdown: 1 buy · 4 sells. Total volume traded: €272k. Activity tracked since 7 July 2021. The latest transaction was disclosed on 2 July 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Mark William Lowdell is the Chief Scientific Officer at Inmune Bio, Inc. In this role, he is responsible for leading the company's research and development initiatives. Mark William Lowdell plays a key role in innovation and scientific advancement within the organization. His expertise in biotechnology and life sciences is essential for supporting Inmune Bio's research objectives. He collaborates with multidisciplinary teams to develop innovative therapeutic solutions.